This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Unipolar Depression
and you are
between 18 and 65
years old
-
The phase for this study is not defined.
Show me locations

The purpose

This study is intended to evaluate the efficacy and safety of lamotrigine as an antidepressant augmentation agent in a sample of individuals with major depression and a history of both prior non-response and prospective failure to respond to at least one adequate trial of an antidepressant (for a total of two failed trials).

Provided treatments

  • Drug: lamotrigine
  • Drug: placebo
  • Drug: paroxetine
Tris trial is registered with FDA with number: NCT00901407. The sponsor of the trial is Louisiana State University Health Sciences Center in New Orleans and it is looking for 138 volunteers for the current phase.
Official trial title:
Lamotrigine as an Antidepressant Augmentation Agent in Treatment Refractory Unipolar Depression